Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04394624
Title SAR408701 in Combination With Ramucirumab in Pre-treated Patients With Non Squamous Non-small Cell Lung Cancer (NSQ NSCLC) (CARMEN-LC04)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi

lung non-squamous non-small cell carcinoma


Ramucirumab + SAR408701

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.